187 related articles for article (PubMed ID: 3080282)
1. Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer.
McGuigan JE; Chang Y; Dajani EZ
Dig Dis Sci; 1986 Feb; 31(2 Suppl):120S-125S. PubMed ID: 3080282
[TBL] [Abstract][Full Text] [Related]
2. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.
Brand DL; Roufail WM; Thomson AB; Tapper EJ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):147S-158S. PubMed ID: 3932048
[TBL] [Abstract][Full Text] [Related]
3. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.
Davis GR; Fordtran JS; Dajani EZ
Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026
[TBL] [Abstract][Full Text] [Related]
4. Effect of misoprostol and antacids on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients.
Vetvik K; Schrumpf E; Andersen KJ; Skagen DW; Halvorsen OJ
Scand J Gastroenterol; 1991 Apr; 26(4):385-91. PubMed ID: 1903558
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial.
Bright-Asare P; Sontag SJ; Gould RJ; Brand DL; Roufail WM
Dig Dis Sci; 1986 Feb; 31(2 Suppl):63S-67S. PubMed ID: 3080291
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.
Lam SK; Lau WY; Choi TK; Lai CL; Lok AS; Hui WM; Ng MM; Choi SK
Dig Dis Sci; 1986 Feb; 31(2 Suppl):68S-74S. PubMed ID: 3080292
[TBL] [Abstract][Full Text] [Related]
7. Overview of misoprostol clinical experience.
Herting RL; Nissen CH
Dig Dis Sci; 1986 Feb; 31(2 Suppl):47S-54S. PubMed ID: 3080288
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
9. Perspective on the gastric antisecretory effects of misoprostol in man.
Dajani EZ
Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
Monk JP; Clissold SP
Drugs; 1987 Jan; 33(1):1-30. PubMed ID: 3102205
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy. A placebo-controlled, multicenter, double-blind, randomized trial.
Newman RD; Gitlin N; Lacayo EJ; Safdi AV; Ramsey EJ; Engel SL; Rubin A; Nissen CH; Swabb EA
Am J Med; 1987 Jul; 83(1A):27-31. PubMed ID: 2887112
[TBL] [Abstract][Full Text] [Related]
13. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050
[TBL] [Abstract][Full Text] [Related]
14. Misoprostol preclinical pharmacology.
Bauer RF
Dig Dis Sci; 1985 Nov; 30(11 Suppl):118S-125S. PubMed ID: 3932042
[TBL] [Abstract][Full Text] [Related]
15. Multiple duodenal ulcer: natural history and pathophysiology.
Hui WM; Lam SK
Gut; 1987 Sep; 28(9):1134-41. PubMed ID: 3119434
[TBL] [Abstract][Full Text] [Related]
16. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
Thomas FJ; Koss MA; Hogan DL; Isenberg JI
Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
[TBL] [Abstract][Full Text] [Related]
17. [A double-blind study with misoprostol in the treatment of active duodenal ulcer].
Mazure PA; Cosen JN; Ciccia JE; Colombato LO; Luis A; Arguto JF; Boffi A
Acta Gastroenterol Latinoam; 1985; 15(1):13-24. PubMed ID: 3937407
[TBL] [Abstract][Full Text] [Related]
18. Effects of misoprostol on gastric acid and mucus secretion in man.
Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of two dosage regimens of misoprostol in the treatment of duodenal ulceration.
Birnie GG; Watkinson G; Shroff NE; Akbar FA
Dig Dis Sci; 1988 Oct; 33(10):1269-73. PubMed ID: 3139379
[TBL] [Abstract][Full Text] [Related]
20. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease.
Mahachai V; Walker K; Sevelius H; Thomson AB
Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
